Management of hyperlipidaemia in primary care: The implications of the National Service Framework for Coronary Heart Disease

British Journal of Cardiology

Volumn 7, Issue SUPPL. 4, 2000, Pages

  Hobbs, R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STATIN; WARFARIN;

ALCOHOL CONSUMPTION; BLOOD PRESSURE MONITORING; BODY WEIGHT; CHOLESTEROL DIET; DIABETES MELLITUS; DIET; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; MEDICAL AUDIT; PHYSICAL ACTIVITY; PRIMARY HEALTH CARE; PRIMARY PREVENTION; REVIEW; RISK FACTOR; RISK MANAGEMENT; SECONDARY PREVENTION; SMOKING CESSATION;

EID: 0033674888     PISSN: 09696113     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. The global burden of disease, 1990-2020
2. Mortality by cause for eight regions of the world: Global burden of disease study
3. Risk factors for ischaemic heart disease: The prospective phase of the British regional heart study
4. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
5. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. The Cholesterol and Recurrent Events Trial (CARE) investigators
6. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
7. Secondary prevention in coronary heart disease: A randomised trial of nurse-led clinics in primary care
8. Secondary prevention of coronary heart disease in primary care: A healthy heart initiative
9. A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events
10. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
11. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
12. Cardiovascular disease risk profiles
13. Coronary and cardiovascular risk estimation for primary prevention: Population validation of a new Sheffield table
14. Prevention of Coronary Heart Disease in Clinical Practice
15. Guidelines for management of hypertension: Report of the third working party of the British Hypertension Society, 1999